The Role of Melatonin in Colorectal Cancer
- 49 Downloads
The prevalence and mortality rate of colorectal cancer have been dramatically rising globally. Currently, colorectal cancer is emerging as the fourth leading cause of death and the third most common malignancy worldwide. The major drawback in colorectal cancer treatment is related to severe adverse events of both chemotherapy and radiation therapy that lead to toxicity and inflammation. Recently, melatonin as an antioxidant, immune-stimulant, and antimutagenic agent has been noticed. Different studies worked on the molecular role of melatonin on carcinogenesis progression. Overall, the anticancer activity of melatonin, combined with its actions via multiple signaling pathways, is considered hugely exciting to use this drug as a possible treatment strategy to cure cancer. Apart from its anticancer potential, this drug has shown to induce modulation of chemotherapy toxicity and improving its therapeutic efficacy. The present review aimed to discuss the possible role of melatonin usage in management of colorectal cancer.
KeywordsColorectal cancer Melatonin Pineal hormones Chemotherapy
Compliance with Ethical Standards
This study was conducted in compliance with the provisions of the Helsinki Declaration.
Conflict of Interest
The authors declare that they have no conflict of interest.
- 4.Chiru AZ, Popescu C, Gheorghe D. Melatonin and cancer. Journal of Medicine and Life. 2014;7(3):373.Google Scholar
- 10.Safiri S, Sepanlou SG, Ikuta KS, Bisignano C, Salimzadeh H, Delavari A, et al. The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet Gastroenterology & Hepatology. 2019. https://doi.org/10.1016/S2468-1253(19)30345-0.CrossRefGoogle Scholar
- 12.Nikbakht HA, Sahraian S, Ghaem H, Javadi A, Janfada M, Hassanipour S, et al. Trends in mortality rates for gastrointestinal cancers in Fars Province, Iran (2005-2015). Journal of Gastrointestinal Cancer. 2019:1–7. https://doi.org/10.1007/s12029-019-00204-1.
- 16.Nikbakht HA, Shokri-Shirvani J, Ashrafian-Amiri H, Ghaem H, Jafarnia A, Alijanpour S, et al. The first screening program for colorectal cancer in the North of Iran. Journal of Gastrointestinal Cancer. 2019:1–7. https://doi.org/10.1007/s12029-019-00226-9.
- 18.Ramdzan AR, Abd Rahim MA, Mohamad Zaki A, Zaidun Z, Mohammed Nawi A. Diagnostic accuracy of FOBT and colorectal cancer genetic testing: a systematic review & meta-analysis. Annals of Global Health. 2019;85(1). https://doi.org/10.5334/aogh.2466.
- 28.Fitzmaurice C, Allen C, Barber RM, Barregard L, Bhutta ZA, Brenner H, et al. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study. JAMA Oncology. 2017;3(4):524–48.PubMedCrossRefPubMedCentralGoogle Scholar
- 29.Edwards BK, Ward E, Kohler BA, Eheman C, Zauber AG, Anderson RN, et al. Annual report to the nation on the status of cancer, 1975-2006, featuring colorectal cancer trends and impact of interventions (risk factors, screening, and treatment) to reduce future rates. Cancer: Interdisciplinary International Journal of the American Cancer Society. 2010;116(3):544–73.CrossRefGoogle Scholar
- 30.Posadzki PP, Bajpai R, Kyaw BM, Roberts NJ, Brzezinski A, Christopoulos GI, et al. Melatonin and health: an umbrella review of health outcomes and biological mechanisms of action. BMC Medicine. 2018;16(1):18–8. https://doi.org/10.1186/s12916-017-1000-8.
- 32.Anisimov VN, Popovich IG, Shtylik AV, Zabezhinski MA, Ben-Huh H, Gurevich P, et al. Melatonin and colon carcinogenesis. III. Effect of melatonin on proliferative activity and apoptosis in colon mucosa and colon tumors induced by 1,2-dimethylhydrazine in rats. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie. 2000;52(1):71–6. https://doi.org/10.1016/s0940-2993(00)80022-6.CrossRefGoogle Scholar
- 47.Sanchez-Barcelo EJ, Mediavilla MD, Alonso-Gonzalez C, Reiter RJ. Melatonin uses in oncology: breast cancer prevention and reduction of the side effects of chemotherapy and radiation. Expert Opinion on Investigational Drugs. 2012;21(6):819–31. https://doi.org/10.1517/13543784.2012.681045.CrossRefPubMedGoogle Scholar
- 57.Srinivasan V, R. Pandi-Perumal S, Brzezinski A, P Bhatnagar K, P Cardinali D (2011) Melatonin, immune function and cancer. Recent Patents on Endocrine, Metabolic & Immune Drug Discovery 5 (2):109-123Google Scholar
- 62.Cerea G, Vaghi M, Ardizzoia A, Villa S, Bucovec R, Mengo S, et al. Biomodulation of cancer chemotherapy for metastatic colorectal cancer: a randomized study of weekly low-dose irinotecan alone versus irinotecan plus the oncostatic pineal hormone melatonin in metastatic colorectal cancer patients progressing on 5-fluorouracil-containing combinations. Anticancer Research. 2003;23(2C):1951–4.PubMedPubMedCentralGoogle Scholar